# Thomas Ruzicka

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/thomas-ruzicka/

## Facts

| Field | Value |
| --- | --- |
| Citations | 39,627 |
| Field | Dermatology and Skin Diseases |
| h-index | 99 |
| i10-index | 519 |
| Last Known Institution | University of Zurich |
| OpenAlex ID | https://openalex.org/A5037531417 |
| ORCID iD | https://orcid.org/0000-0002-9596-1749 |
| Works | 1,100 |

## Researcher papers

- [Anti–Interleukin-31 Receptor A Antibody for Atopic Dermatitis](https://scholariq.org/papers/anti-interleukin-31-receptor-a-antibody-for-atopic-dermatitis/)
- [Efficacy and safety of oral alitretinoin (9-cis retinoic acid) in patients with severe chronic hand eczema refractory to topical corticosteroids: results of a randomized, double-blind, placebo-controlled, multicentre trial](https://scholariq.org/papers/efficacy-and-safety-of-oral-alitretinoin-9-cis-retinoic-acid-in-patients-with/)
- [European S1 guidelines on the management of lichen planus: a cooperation of the European Dermatology Forum with the European Academy of Dermatology and Venereology](https://scholariq.org/papers/european-s1-guidelines-on-the-management-of-lichen-planus-a-cooperation-of-the/)

## Researcher topics

- [Dermatology and Skin Diseases](https://scholariq.org/topics/dermatology-and-skin-diseases/)
- [Autoimmune Bullous Skin Diseases](https://scholariq.org/topics/autoimmune-bullous-skin-diseases/)
- [Psoriasis: Treatment and Pathogenesis](https://scholariq.org/topics/psoriasis-treatment-and-pathogenesis/)
- [Nonmelanoma Skin Cancer Studies](https://scholariq.org/topics/nonmelanoma-skin-cancer-studies/)
- [Cutaneous Melanoma Detection and Management](https://scholariq.org/topics/cutaneous-melanoma-detection-and-management/)

## Researcher university

- [University of Zurich](https://scholariq.org/institutions/university-of-zurich/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.